(b)(4) the lot number was not provided.Therefore the udi is not available.The review of the manufacturing paperwork could not be performed as the lot number(s) were not available.According to the gore® viabahn® endoprosthesis instructions for use (ifu), device-related complications and adverse events include, but are not limited to thrombosis or occlusion of device.
|
On (b)(6) 2017, this patient underwent endovascular procedure to repair a traumatic pseudoaneurysm of the right subclavian artery using a gore® viabahn® endoprosthesis.There was a thrombotic occlusion distal to the pseudoaneurysm, and thrombectomy was performed with a fogarty catheter from the right brachial artery approach prior to a delivery of the endoprosthesis.The patient tolerated the procedure.On an unknown date around august, follow-up computed tomography (ct) showed a stenosis of the endoprosthesis.The patient was taking mono antiplatelet (bay aspirin), and plavix was additionally administered at that time.On (b)(6) 2017, it was reported that the latest ct (date unknown) confirmed an occlusion of the endoprosthesis.Noac was additionally administered.No clinical symptoms were reportedly observed, and the patient is being monitored.Reportedly, the physician suspected that the event was contributed by the patient's predisposition since the occlusion occurred even with dual-antiplatelet drugs.Also, the lesion was reportedly located near the shoulder joint, and this condition reportedly may have contributed to the event as well.
|